Cohen Steven P, Keshwani Ariz A, Khan Dost, Stojanovic Milan P
Departments of Anesthesiology, Neurology, Physical Medicine & Rehabilitation, Psychiatry and Neurological Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Departments of Anesthesiology and Physical Medicine & Rehabilitation, Walter Reed National Military Medical Center, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.
Interv Pain Med. 2025 May 9;4(2):100574. doi: 10.1016/j.inpm.2025.100574. eCollection 2025 Jun.
Epidural steroid injections are indicated for radicular pain, with a pre-injection MRI not mandated in guidelines. There is conflicting evidence that MRI findings correlate with outcomes.
Fourteen patients with near-normal imaging (i.e., no evidence of nerve root compression and minor degenerative changes if present) who underwent ESI for lumbosacral radicular pain and were followed for up to 12 weeks were propensity matched against 14 patients with radicular pain secondary to concordant MRI pathology. The primary outcome measure was mean reduction in average leg pain relief at 4 and 12 weeks. Secondary outcome measures included average back pain, function, analgesic reduction, satisfaction, and a categorical measure of success predesignated as a ≥2-point decrease in average leg pain score coupled with a positive global perceived effect and not requiring any additional intervening interventions.
For mean reduction in average leg pain at 4 weeks, there were no significant differences between those with near-normal MRIs and those with abnormal imaging (2.36 (SD 2.55) vs. 2.61 (SD 2.15); P = 0.72). For average back pain reduction at the same time point, the mean reduction was 0.75 (1.73) among cases vs. 1.07 (2.01) in control patients (P = 0.57). There were also no differences observed in pain reduction outcomes at 12 weeks. The average reduction in Oswestry Disability Index at 12 weeks favored the near-normal imaging group (8.64 % (SD 11.36) vs. 0 % (7.69); P = 0.047). A trend was noted wherein more patients with abnormal imaging experienced a positive outcome at 4 weeks (50 % vs. 28.57 %; P = 0.22) but not 12 weeks (28.57 % in both groups).
There were no significant differences in pain outcomes compared to control patients, though patients with near-normal imaging fared worse than historical controls and the larger cohort from which propensity-matched patients were selected. The possibility of poorer outcomes should be considered when selecting patients with normal imaging and radiculopathy for ESI.
硬膜外类固醇注射适用于神经根性疼痛,指南中未强制要求注射前进行磁共振成像(MRI)检查。关于MRI检查结果与治疗效果之间的相关性,证据存在矛盾。
对14例影像学表现接近正常(即无神经根受压证据,如有则为轻微退变改变)且因腰骶神经根性疼痛接受硬膜外类固醇注射(ESI)并随访长达12周的患者,与14例因MRI检查结果相符的病理改变继发神经根性疼痛的患者进行倾向评分匹配。主要结局指标为4周和12周时平均腿痛缓解程度的平均降低值。次要结局指标包括平均背痛、功能、镇痛药使用减少情况、满意度,以及预先设定的成功分类指标,即平均腿痛评分降低≥2分,同时伴有积极的整体感觉效果且无需任何额外干预措施。
在4周时平均腿痛的平均降低值方面,MRI表现接近正常的患者与影像学异常的患者之间无显著差异(分别为2.36(标准差2.55)和2.61(标准差2.15);P = 0.72)。在同一时间点的平均背痛减轻方面,病例组的平均减轻值为0.75(1.73),而对照组患者为1.07(2.01)(P = 0.57)。12周时的疼痛减轻结局也未观察到差异。12周时Oswestry功能障碍指数的平均降低值有利于影像学接近正常的组(8.64%(标准差11.36)对0%(7.69);P = 0.047)。注意到一种趋势,即影像学异常的患者在4周时有更多患者取得了阳性结局(50%对28.57%;P = 0.22),但在12周时并非如此(两组均为28.57%)。
与对照组患者相比,疼痛结局无显著差异,尽管影像学接近正常的患者比历史对照组以及从中选择倾向评分匹配患者的更大队列表现更差。在为ESI选择影像学正常且患有神经根病的患者时,应考虑结局较差的可能性。